SCHEMBL31283680

SCHEMBL31283680

C[C@@H](N[S@+]([O-])C(C)(C)C)c1cc(F)cc2c(=O)c3c(oc12)-c1cccnc1CC3

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31283931 0.82 MAPK14 (0.34) MAPK14
SCHEMBL31284377 0.77 PIK3CA (0.35) MAPK14
SCHEMBL31283781 0.77 — —
SCHEMBL31284922 0.75 PIK3CA (0.48) —
SCHEMBL31284129 0.75 PIK3CA (0.34) MAPK14
SCHEMBL31285230 0.75 MAPK14 (0.36) MAPK14
SCHEMBL31284141 0.74 MAPK14 (0.34) MAPK14
SCHEMBL31284323 0.73 — —
SCHEMBL31284225 0.70 MAPK14 (0.40) MAPK14
SCHEMBL24913153 0.65 PIK3CA (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731626-A1 PI3K INHIBITORS AND USE THEREOF Regor Pharmaceuticals, Inc. (US) 2026-04-29 — — EP disclosed
WO-2024260464-A1 PI3K INHIBITORS AND USE THEREOF REGOR PHARMACEUTICALS, INC. (US) 2024-12-26 — — WO disclosed
Send feedback